Call:
86-27-6552 3378
or
Contact Us
Login
|
Register
Home
About us
Company information
Photo albums
Privacy statement
News
Abebio News
Biological News
Promotions
Products
ELISA Kits
Proteins
Antibodies
Nucleic Acid Extraction Kits
Exosome Extraction Kits
IVD Raw Material
Service
Protein Service
Antibody Service
Kit Service
Technical support
FAQs
Catalog/Brochures
Terms and Conditions
Publications
Contact
Contact us
NEWS
Abebio News
Biological News
Promotions
Current Position:
Home
>>
News
>>
Biological News
Search articles:
News
Diseased cell fragments burst from pockets in immune cells to activate response
Researchers at the Francis Crick Institute have uncovered an important process in how our immune system detects signs of disease and activates a protective response.
Read More
28
Dec,2020
COVID immunity lasts at least eight months, new data reveals
Australian researchers have revealed-for the first time-that people who have been infected with the COVID-19 virus have immune memory to protect against reinfection for at least eight months. The research is the strongest evidence for the likelihood that vaccines against the virus, SARS-CoV-2, will work for long periods.
Read More
28
Dec,2020
Hepatitis C Virus Faces New Weapon: Novel Genetic Screening Method Can Identify Drug-Resistant HCV Strains
ScienceDaily-In recent human trials for a promising new class of drug designed to target the hepatitis C virus (HCV) without shutting down the immune system, some of the HCV strains being treated exhibited signs of drug resistance.
Read More
28
Dec,2020
Study sheds light on immune mechanism that triggers cytokine storm typical of COVID-19
Researchers at the University of São Paulo (USP) in Brazil have demonstrated for the first time that in COVID-19 patients an immune mechanism known as the inflammasome participates in activation of the inflammatory process that can damage several organs and even lead to death.
Read More
27
Nov,2020
Your body clock determines your weight
Recently, a discovery from the Garvan Institute of medical research in Australia revealed that an important signal system in the brain controls appetite, energy consumption and body fat composition. One of the specific genes determines the bodys weight.
Read More
27
Nov,2020
The largest trial of patients with EGFR mutation-positive NSCLC
RIDGEFIELD, Conn., June 4, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the companys pivotal Phase III clinical trial, LUX-Lung 3, investigating afatinib as a first-line treatment in patients with stage IIIb or IV non-small cell lung cancer (NSCLC) harboring an epidermal growth factor receptor (EGFR) mutation, met its primary endpoint of progression-free survival (PFS).
Read More
27
Nov,2020
[1]
...
[<<]
-
[<]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[>]
-
[>>]
...
[50]
We use cookies to make our site as useful as possible
. Our
Cookie Policy
explains how you can opt-out of the cookies we use. If you continue without changing your cookie settings, we'll assume you're happy with this.
Accept Cookies